₨ 57,000.00
MBBS
TARCEVA 25mg Tablet 30s
- Does this requires a prescription ? Yes
- Generic Name: Erlotinib:25mg
- Manufactured by : Roche
- Drug Strength : 25mg
- Drug Form : Tablet
- Pack Size : 30s
- Product SKU : dis_20570
Erlotinib:25mg | Cytotoxic (anti-neoplastic) drugs
Manufactured / Marketed By : Roche Product Form : TabletPack Size : 30sIngredients : Erlotinib:25mgGeneric Category : Cytotoxic (anti-neoplastic) drugs
How it works
TARCEVA 25mg Tablet 30s works by blocking the growth and multiplication of cancer cells.
Side effects
Major & minor side effects for TARCEVA 25mg Tablet 30s
- Burning or tingling sensation
- Cough
- Diarrhea severe
- Lower back or side pain
- Chills and fever
- Rash severe
- Blurred vision
- Convulsions (seizures)
- Chest pain or discomfort
- Acid or sour stomach
- Hair loss
- Loss of appetite
Uses of TARCEVA 25mg Tablet 30s
What is it prescribed for?
-
Non-Small Cell Lung Cancer
This medicine is used for the treatment of non-small cell lung cancer, a disease characterized by symptoms such as a persistent cough, shortness of breath, weight loss, coughing up blood, etc.
-
Pancreatic Cancer
This medicine is used in a combination with gemcitabine for the treatment of pancreatic cancer.
Concerns
Frequently asked questions
-
Onset of action
The amount of time required for this medicine to show its action is not clinically established.
-
Duration of Effect
The amount of time for which this medicine remains active in the body is not clinically established.
-
Safe with Alchohol?
Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
-
Is it habit forming?
No habit-forming tendencies were reported.
-
Usage in pregnancy?
This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
-
Usage while breast-feeding?
This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the medicine based on your clinical condition.
When not to use?
-
Allergy
This medicine is not recommended for use in patients with a known allergy to erlotinib or any other inactive ingredients present along with this medicine.
Warnings
-
Pregnancy
This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
-
Breast-feeding
This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the medicine based on your clinical condition.
-
Anticoagulants
This medicine should be used with caution in patients receiving anticoagulants due to the increased risk of excessive bleeding. Close monitoring of INR, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.
-
Hepatic Impairment
This medicine should be used with caution in patients suffering from liver diseases due to the increased risk of worsening of the patient's condition. Close monitoring of liver function tests is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.
-
Renal Impairment
This medicine should be used with caution in patients suffering from kidney diseases due to the increased risk of severe adverse effects. Close monitoring of kidney function, appropriate dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition of the patient.
-
Gastrointestinal Perforations
This medicine should be used with extreme caution in patients suffering from gastrointestinal diseases due to the increased risk of gastrointestinal perforations. Report any unusual symptoms to the doctor immediately. Close monitoring of clinical condition or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.
Dosage
-
Missed Dose
The missed dose should be taken as soon as possible. It is advisable to skip the missed dose if it is already time for your next scheduled dose. Do not use extra medicine to make up for the missed dose.
-
Overdose
Seek emergency medical treatment or contact the doctor in case of an overdose.
Interactions
Interaction with Medicines- Atazanavir moderate
- Ciprofloxacin moderate
- Carbamazepine moderate
- Clarithromycin moderate
- Lansoprazole severe
- Pantoprazole severe
- Fluvoxamine moderate
-
severe
This medicine should be used with extreme caution in patients suffering from gastrointestinal diseases such as peptic ulcer disease and diverticular disease due to the increased risk of worsening of the patient's condition. Close monitoring of clinical condition, appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.
-
severe
This medicine should be used with extreme caution in patients suffering from eye diseases such as primary keratitis, ulcerative keratitis, conjunctivitis, etc. due to an increase in the risk of worsening of the patient's condition. Report any unusual symptoms or worsening of eye symptoms to the doctor immediately. Close monitoring of clinical condition or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.
-
severe
This medicine should be used with caution in patients with a history of kidney diseases due to the increased risk of severe adverse effects. Close monitoring of kidney function, appropriate dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.
-
severe
This medicine should be used with extreme caution in patients suffering from liver diseases due to the increased risk of worsening of the patient's condition. Close monitoring of liver function is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition of the patient.
-
Consumption of grapefruit juice is not recommended during treatment with this medicine due to the increased risk of severe adverse effects such as nausea, vomiting, diarrhea, etc.
General Instructions
Take this medicine as instructed by the doctor. You are advised to take it on an empty stomach, at least 1 hour before or 2 hours after a meal. Do not take in larger or smaller amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor.
Other details
- To be taken on an empty stomach
- To be taken as instructed by doctor
- Effect on sleep is not established
References
- medlineplus - Erlotinib [Internet]. Available from: https://medlineplus.gov/druginfo/meds/a605008.html [cited 2/11/2021]. 2021
One of the following licensed pharmacy from the nearest location will deliver TARCEVA 25mg Tablet 30s. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.
Questions and Answers
There are no questions yet. Be the first to ask a question about this product.
Related products
Products listed on medicalstore.com.pk are 100% genuine and sourced from licensed pharmacies.
We work hard to bring you unimaginable discounts without compromising on quality.
We uses SSL (standard security technology) to ensure data privacy of all our customers.
Reviews
There are no reviews yet.